Ad Code

Cleaning Validation Acceptance Criteria and Limits

WebOfPharma · Cleaning validation controls

Cleaning Validation Acceptance Criteria and Limits

A practical GMP guide to health-based residue limits, MACO, visual inspection, swab and rinse criteria, detergents, microbial controls and QA decisions.

Acceptance criteria MACO & HBEL Swab & rinse limits GMP release
Cleaning Validation Acceptance Criteria and Limits
Quick answer: Cleaning-validation acceptance criteria are predefined, scientifically justified requirements used to decide whether equipment is clean and suitable for the next product. A complete set normally covers previous-product residue against a health-based MACO limit, visual cleanliness, detergent residue, microbial or endotoxin contamination where relevant, cleaning-process parameters, sample recovery and analytical capability. Every criterion should be measurable, achievable, documented before execution and reviewed by Quality Assurance.

Cleaning Validation Acceptance Criteria and Limits are the decision rules that turn a cleaning study into a defensible GMP conclusion. They define what must be true before a shared vessel, blender, granulator, filling line, hose or transfer path can be released for the next product. A limit that is too high can fail to protect patients; a limit that is below method capability cannot be verified reliably.

This guide explains how to set, justify, calculate, test and approve cleaning-validation limits using health-based exposure limits, MACO, direct surface sampling, rinse sampling and supporting visual and microbiological controls. It is designed for pharmaceutical Production, QC, QA, Validation, Engineering and Toxicology teams.

Core principle: acceptance criteria must be predetermined. Do not change a limit after seeing the result, average away a high location or repeat samples until a passing value appears without a documented investigation.

What are cleaning-validation acceptance criteria?

Acceptance criteria are the predefined requirements that an executed cleaning process must meet. They are written in the approved protocol and linked to the cleaning SOP, risk assessment, analytical method, equipment train and product sequence.

Criteria should answer four questions:

  • What is measured? Active residue, marker, detergent, microbial count, endotoxin, visual condition or process parameter.
  • Where is it measured? Product-contact surfaces, difficult locations, rinse paths, equipment outlets or defined hold points.
  • How is it measured? Validated swab, rinse, visual inspection, conductivity, TOC, HPLC, microbiology or another justified method.
  • What is pass or fail? A numerical limit, no-detectable-residue requirement, range, alert/action limit or documented decision rule.

The criteria must be specific enough that two qualified reviewers would reach the same decision from the same data.

Acceptance-criteria hierarchy

Health

HBEL/MACO

Controls previous-product carryover using approved toxicological and product-pair inputs.

Appearance

Visual cleanliness

Confirms no visible residue under defined lighting, access and inspection conditions.

Chemistry

Detergent and marker

Controls cleaning-agent residues and product-specific markers that affect quality.

Microbiology

Bioburden and endotoxin

Controls microbial or endotoxin risk when product, process or route requires it.

These criteria work together. A result below a chemical limit does not override visible residue, failed equipment release, an out-of-range cleaning parameter or unacceptable microbial evidence.

Regulatory and GMP foundation

Your site’s cGMP system should require cleaning limits that are documented, practical, achievable and verifiable. FDA cleaning guidance emphasizes residue limits based on factors such as potency, toxicity, solubility, stability and difficulty of cleaning, with methods sensitive enough to detect the established acceptable level.

The protocol should identify equipment, cleaning procedure, materials, acceptable levels, monitored parameters and analytical methods. Shared equipment may need additional testing or monitoring after cleaning between campaigns, depending on the risk.

Regulatory note: No single generic limit is suitable for every product or facility. The approved toxicological assessment, current product information, equipment design, analytical method and local regulatory commitments control the final criteria.

Health-based residue limits and MACO

For active or product residues, the primary acceptance criterion is usually derived from an approved health-based exposure limit such as PDE or ADE. The value is combined with the next product’s minimum batch size and maximum daily dose to calculate maximum allowable carryover.

MACO (mg) = [HBEL/PDE/ADE of previous product (mg/day) × minimum batch size of next product (mg)] ÷ maximum daily dose of next product (mg/day) Surface limit (µg/cm²) = [MACO (mg) × 1,000] ÷ total shared product-contact area (cm²) Swab limit (µg/swab) = surface limit (µg/cm²) × approved swab area (cm²)

The calculation must show source data, unit conversions, surface-area assumptions, recovery correction, reporting units and rounding rules. For a complete explanation and worked MACO examples, see Cleaning Validation in Pharmaceuticals.

Worked example: setting a swab acceptance limit

Assume the approved PDE of the previous product is 0.01 mg/day. The next product has a minimum batch size of 5 kg and a maximum daily dose of 250 mg/day. The shared equipment train has 100,000 cm² of product-contact area, and the swab area is 25 cm².

InputValueControl point
Previous-product PDE0.01 mg/dayCurrent approved toxicological value
Next-product minimum batch5 kg = 5,000,000 mgSmallest planned batch
Next-product maximum daily dose250 mg/dayHighest relevant approved dose
Shared contact area100,000 cm²Complete equipment train
Swab area25 cm²Approved sample template
MACO = (0.01 × 5,000,000) ÷ 250 = 200 mg total previous-product residue Surface limit = (200 mg × 1,000 µg/mg) ÷ 100,000 cm² = 2 µg/cm² Swab limit = 2 µg/cm² × 25 cm² = 50 µg per swab

If the method reports recovery-corrected results, each 25 cm² swab must be no more than 50 µg. If the recovery is 80% and raw results are reported, the raw limit corresponding to 50 µg corrected is 40 µg. The protocol must specify the reporting convention so recovery is not applied twice.

Visual-cleanliness acceptance criteria

Visual inspection is a critical minimum control, but it must be written as a controlled test rather than “operator looks at equipment.” The SOP and protocol should define:

  • Inspection locations and access points
  • Lighting intensity or inspection conditions
  • Required disassembly and viewing angles
  • Inspection timing after cleaning and drying
  • Training and qualification of inspectors
  • Definition of visible residue or film
  • Use of mirrors, borescopes or other aids
  • Documentation of each inspected area
  • Handling of obscured or inaccessible locations
  • Escalation when visual status is uncertain

“No visible residue” does not prove that sub-visible chemical residue is absent. Use validated analytical sampling when health, product-quality or process risk requires evidence below the visual-detection capability.

Swab-sampling acceptance criteria

Direct swab acceptance criteria should be tied to a defined area and a validated recovery study. A swab result cannot be interpreted without knowing the area sampled, extraction volume, dilution, recovery, reporting unit and equipment location.

ElementWhat the protocol should defineCommon failure
Swab areaExact area, template, shape and unit.Operators sample different areas and compare results to one limit.
LocationWorst-case and representative product-contact points.Only easy-to-clean locations are sampled.
RecoverySurface-specific recovery and correction convention.Recovery is assumed to be 100% or applied twice.
Result unitµg/swab, µg/cm², ppm or concentration with conversion.Laboratory and validation units are not reconciled.
Decision ruleIndividual, composite, average, maximum and invalid-sample rules.A high result is hidden by an average or unplanned resampling.

Rinse-sampling acceptance criteria

Rinse sampling can support inaccessible pipes, transfer lines or internal paths, but the criterion must account for rinse volume, recovery, distribution and analytical concentration. The protocol should explain why the rinse represents the equipment surface and how the result is converted to an equivalent residue mass.

  • Define the rinse solvent, volume, contact time, flow path and collection point.
  • Demonstrate rinse recovery and sample stability.
  • Specify whether the criterion is concentration, total mass or equivalent surface residue.
  • Use direct surface sampling where feasible for difficult or high-risk locations.
  • Do not use a clear rinse appearance as a substitute for analytical evidence.

A rinse-only strategy should have a documented scientific rationale. The method must be sensitive to the established limit and representative of the residues that could remain on the equipment.

Detergent and cleaning-agent residue limits

Previous-product MACO does not automatically control detergent, sanitizer or cleaning-agent carryover. Set a separate criterion using the chemical’s toxicity, concentration, rinse behavior, intended use, supplier information and potential impact on the next product.

Identity

Know the agent

Record formulation, active components, concentration and safety information.

Method

Measure it

Use specific assay, conductivity, TOC or another justified method.

Limit

Set a rationale

Define an approved acceptance level or no-detectable-residue criterion.

Rinse

Control removal

Demonstrate that the final rinse and drying process remove the agent.

Microbial and endotoxin acceptance criteria

Microbial and endotoxin criteria depend on dosage form, route, process, water quality, equipment hold time and product sensitivity. They should be justified through the contamination-control strategy rather than copied from a chemical residue limit.

RiskPossible criterion or controlEvidence
BioburdenTotal count or process-specific limit.Microbiological sample, validated method and trend.
Objectionable organismsAbsence or defined organism-specific requirement.Approved method and investigation rules.
EndotoxinRoute- and product-appropriate limit.Validated endotoxin method, sample handling and hold-time evidence.
Moisture or wet holdMaximum time before drying, storage or reuse.Hold-time validation and equipment-status control.
Water qualityApproved water grade and final-rinse requirement.Utility monitoring and cleaning record.

Analytical capability and LOQ

Acceptance criteria are only meaningful when the analytical method can detect them. Before protocol approval, compare the final limit with the method’s LOQ and confirm that recovery, specificity, precision, accuracy and sample stability are suitable.

  • LOQ below the final acceptance limit
  • Specificity for active or marker
  • Recovery on relevant surfaces
  • Accuracy and precision near the limit
  • Blank and positive controls
  • Sample and solution stability
  • Validated dilution and calculation factors
  • System suitability and standards
  • Below-LOQ reporting rule
  • Invalid-result and deviation procedure
Never raise a health-based limit to match the LOQ. If the method cannot measure the limit, improve the method, revise sampling, use a justified marker, redesign the equipment or reassess whether shared manufacture is appropriate.

Alert limits, action limits and acceptance limits

A validation acceptance limit is not always the same as a routine alert or action limit. Define the purpose of each limit before using it in a monitoring program.

Limit typePurposeTypical response
Validation acceptance limitDecides whether the planned cleaning study meets its predefined criterion.Pass, fail or documented invalidation with investigation.
Routine alert limitSignals a possible adverse trend before the validated limit is exceeded.Review trend, cleaning parameters, sampling and operator factors.
Routine action limitTriggers a defined quality response during ongoing verification.Investigation, batch/equipment impact assessment and CAPA if needed.
Visual-release criterionControls equipment status before use.Hold equipment, reclean, investigate or release with documented QA decision.

Alert limits must not be used to weaken the final validated acceptance limit. Their purpose is to detect drift early and support proactive control.

Step-by-step process for setting limits

01

Define the product pair

Identify previous product, next product, sequence, dosage form and shared equipment.

02

Review health risk

Obtain current HBEL/PDE/ADE and identify sensitizer, potency, microbial and quality hazards.

03

Calculate MACO

Use minimum next batch, maximum daily dose and complete shared surface area.

04

Set visual criteria

Define inspection conditions, locations, access and visible-residue decision rules.

05

Set chemical criteria

Define active, marker, detergent and degradant limits with approved methods.

06

Set microbial criteria

Assess bioburden, objectionable organisms, endotoxin, wet hold and water quality.

07

Confirm methods

Verify LOQ, specificity, recovery, precision, stability and reporting units.

08

Approve before execution

QA, QC, Validation, Toxicology and Production approve the protocol and criteria.

Acceptance criteria and equipment qualification

Limits must be achievable on the actual equipment. Confirm that the design, installed components, operating ranges and performance evidence support the sampling map and cleaning method.

Requirements

URS

Defines cleanability, access, containment, materials and intended use.

Design

DQ

Confirms the equipment design can meet contamination-control requirements.

Installation

IQ

Verifies installed materials, components, utilities and identification.

Operation

OQ

Challenges cleaning recipes, ranges, alarms and operating controls.

PQ and cleaning-validation execution demonstrate that the qualified equipment and approved cleaning process can meet the criteria during actual use.

Deviations, OOS results and CAPA

A result outside an acceptance limit is a quality event, not an invitation to resample casually. The response should protect the original evidence and assess whether the cleaning process, sample, laboratory method or calculation caused the outcome.

EventImmediate controlInvestigation focus
Visible residueHold equipment and prevent use.Cleaning execution, inspection conditions, equipment design and operator training.
Swab above limitQuarantine equipment and affected product decisions.Location, recovery, sample integrity, cleaning parameters and laboratory data.
Rinse failureHold equipment and evaluate sample representativeness.Rinse path, volume, extraction, distribution and difficult surfaces.
Invalid laboratory resultPreserve original data and follow the laboratory deviation SOP.Instrument, method, standard, calculation, analyst and sample chain of custody.
Repeated trend excursionEscalate through Quality and change control.Process capability, equipment maintenance, detergent, hold time and CAPA.

Use the site’s CAPA system for systemic actions and the established CAPA procedure for investigation, action ownership and effectiveness review.

Data integrity and documentation

Acceptance limits are only defensible when the supporting data are complete and traceable. Apply ALCOA+ to calculations, worksheets, laboratory results, chromatograms, audit trails, sample labels, equipment status and approvals.

  • Use the current controlled SOP and protocol revision.
  • Record actual cleaning parameters, not only planned values.
  • Preserve original sample identifiers, chain of custody and raw data.
  • Control formulas, conversions, recovery corrections and rounding.
  • Assess applicable 21 CFR electronic-record and signature controls.

QA approval checklist

  • Criteria are approved before validation execution.
  • HBEL/PDE/ADE and MACO inputs are current and traceable.
  • Minimum batch and maximum dose are justified.
  • Complete equipment-contact area is documented.
  • Swab and rinse limits match sampling methods.
  • Visual inspection conditions are defined.
  • Detergent and microbial criteria are addressed.
  • Analytical LOQ is below the final acceptance limit.
  • Recovery and correction are validated and applied once.
  • Individual, composite and resampling rules are clear.
  • Deviation, OOS, CAPA and revalidation triggers are defined.
  • Data-integrity and approval records are complete.

Frequently asked questions

What are cleaning-validation acceptance criteria?

They are predefined requirements used to decide whether a cleaning process has removed chemical, microbial and other contaminants to an acceptable level and whether equipment can be released.

What is the primary chemical limit?

For active residues, the primary limit is usually based on an approved health-based exposure limit such as PDE or ADE and converted into MACO and sample-specific criteria.

Is “no visible residue” enough?

No. Visual inspection is an important minimum control, but sub-visible chemical residue may require validated swab or rinse testing.

How is a swab limit calculated?

Divide MACO by the complete shared product-contact area to obtain a surface limit, then multiply by the defined swab area and apply the approved recovery convention.

Can rinse sampling be used alone?

Only when the scientific rationale demonstrates that the rinse represents the relevant equipment surfaces. Direct surface sampling should be used where feasible for difficult or high-risk locations.

What is the role of detergent limits?

Detergent or cleaning-agent residues require a separate acceptance rationale because the active-product MACO does not automatically control chemical cleaning agents.

What if the acceptance limit is below the analytical LOQ?

Do not raise the limit to the LOQ. Improve the method, revise sampling, use a justified marker, redesign equipment or evaluate dedication.

Should every location meet the limit?

The protocol should define whether limits apply to each individual location, a composite, a maximum value or another justified decision rule. High-risk locations should not be hidden by averaging.

What happens after a failed cleaning result?

Hold equipment, preserve original data, investigate cleaning, sampling and laboratory causes, assess product impact and implement CAPA or revalidation when justified.

When should criteria be revised?

Review them after changes to products, toxicology, equipment, detergent, cleaning parameters, methods, batch sizes, campaign length, failures or regulatory expectations.

Conclusion

Cleaning Validation Acceptance Criteria and Limits should be scientifically justified, measurable, practical and approved before study execution. A defensible set combines health-based MACO limits with visual, detergent, microbiological, process-parameter and analytical controls.

When the criteria are linked to current product and equipment data, validated methods, cGMP, ALCOA+ and lifecycle change control, the cleaning decision is transparent and repeatable. The result is stronger patient protection, better batch-release confidence and clearer inspection evidence.

Further reading

This educational article explains common cleaning-validation criteria. Always use the current approved toxicological assessment, site procedures, validated methods and applicable regulatory requirements for implementation.